EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -0.074
March 31, 2026 -0.0811
December 31, 2025 0.6002
September 30, 2025 -0.0746
June 30, 2025 -0.0785
March 31, 2025 -0.0778
December 31, 2024 -0.0683
September 30, 2024 0.0142
June 30, 2024 -0.0237
March 31, 2024 -0.0812
December 31, 2023 0.1099
September 30, 2023 -0.1116
June 30, 2023 -0.1064
March 31, 2023 -0.1078
December 31, 2022 -0.0357
September 30, 2022 -0.1356
June 30, 2022 -0.1057
March 31, 2022 -0.1123
December 31, 2021 -0.1013
September 30, 2021 -0.0733
June 30, 2021 -0.1133
March 31, 2021 -0.1184
December 31, 2020 -0.103
September 30, 2020 -0.0933
June 30, 2020 -0.0768
Date Value
March 31, 2020 -0.1014
December 31, 2019 -0.0955
September 30, 2019 -0.0992
June 30, 2019 -0.0972
March 31, 2019 -0.1401
December 31, 2018 -0.1578
September 30, 2018 -0.0544
June 30, 2018 -0.1955
March 31, 2018 0.002
December 31, 2017 -0.18
September 30, 2017 -0.19
June 30, 2017 -0.18
March 31, 2017 -0.17
December 31, 2016 -0.17
September 30, 2016 -0.15
June 30, 2016 -0.13
March 31, 2016 -0.17
December 31, 2015 -0.01
September 30, 2015 -0.13
June 30, 2015 -0.13
March 31, 2015 -0.12
December 31, 2014 -0.03
September 30, 2014 -0.11
June 30, 2014 -0.05
March 31, 2014 -0.04

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Pluri, Inc. -0.5432
Evogene Ltd. -0.1449
Scinai Immunotherapeutics Ltd. -3.662
CollPlant Biotechnologies Ltd. -1.890
Regentis Biomaterials Ltd. --